HALO logo
halo search icon
Fate Therapeutics, Inc.

US$1.84

Price Change Indicator
-0.05 (-2.646%)
Fate Therapeutics, Inc.
FATE · NAS

Fate Therapeutics, Inc.

Start Trading FATE for Free

US$1.84

Price Arrow-0.05 (-2.646%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueHammer Bullish (Realtime)Recent Earnings upgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Fate Therapeutics, Inc. Overview

FATE Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About FATE

icon
icon

Telephone

1.858.875.1800

icon

Address

12278 Scripps Summit Drive, San Diego, CA 92131

Description

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.

FATE Price Chart

Key Stats

Market Cap

US$220.30M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.91 - 2.46

Trade Value (12mth)

US$629,081.00

1 week

7.69%

1 month

40%

YTD

91.61%

1 year

61.54%

All time high

121.16

Key Fundamentals

EPS 3 yr Growth

-60.60%

EBITDA Margin

NaN%

Operating Cashflow

-$106m

Free Cash Flow Return

-31.30%

ROIC

-40.30%

Interest Coverage

0.00

Quick Ratio

5.80

Other Data

Shares Outstanding (Fully Diluted)

120m

HALO Sector

Healthcare

Next Company Report Date

01-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

FATE Announcements

Latest Announcements

DateAnnouncements
13 May 26
13 May 26
13 May 26
13 May 26
27 February 26

FATE Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.64-1.64-1.15locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.64-1.64-1.15locklocklock
Growth
 %locklocklocklock43.8-0.230locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Fate Therapeutics, Inc. (FATE:NAS)?
Halo FAQ
The current share price of Fate Therapeutics, Inc. (FATE:NAS) is USD$1.84.
What is the 52-week high share price for Fate Therapeutics, Inc. (FATE:NAS)?
Halo FAQ
The 52-week high share price for Fate Therapeutics, Inc. (FATE:NAS) is USD$2.46.
What is the 52-week low share price for Fate Therapeutics, Inc. (FATE:NAS)?
Halo FAQ
The 52-week low share price for Fate Therapeutics, Inc. (FATE:NAS) is USD$0.91.
What is the dividend yield for Fate Therapeutics, Inc. (FATE:NAS)?
Halo FAQ
Fate Therapeutics, Inc. (FATE:NAS) does not pay a dividend.
What was Fate Therapeutics, Inc. (FATE:NAS) last dividend payment?
Halo FAQ
Fate Therapeutics, Inc. (FATE:NAS) does not pay a dividend.
What is the franking level for Fate Therapeutics, Inc. (FATE:NAS)?
Halo FAQ
Fate Therapeutics, Inc. (FATE:NAS) has a franking level of 0.00%.
In which sector is Fate Therapeutics, Inc. (FATE:NAS) classified?
Halo FAQ
Fate Therapeutics, Inc. (FATE:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial